These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6980843)

  • 1. Cell-mediated effector mechanisms in aging humans.
    Marcano NB; Rivas A; Figarella EF; Blanca I; Penchaszadeh GK; Pérez-Rojas G; Bianco NE
    Int Arch Allergy Appl Immunol; 1982; 69(1):7-11. PubMed ID: 6980843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of specific cell-mediated cytotoxicity by monoclonal antibodies to human T cell antigens.
    Platsoucas CD; Good RA
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4500-4. PubMed ID: 6974866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous and antibody-dependent cell-mediated cytotoxicity by human T cell subpopulations.
    Gupta S; Fernandes G; Nair M; Good RA
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5137-41. PubMed ID: 311006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of elevated temperature on natural killer cell activity, lymphokine-activated killer cell activity and lectin-dependent cytotoxicity of human umbilical cord blood and adult blood cells.
    Shen RN; Lu L; Young P; Shidnia H; Hornback NB; Broxmeyer HE
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):821-6. PubMed ID: 8040029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage.
    Vargas-Cortes M; Hammarström ML; Hammarström S; Hellström U; Perlmann P
    Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME; Hiserodt JC
    J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target cell-directed inactivation and IL-2-dependent reactivation of LAK cells.
    Xiao J; Brahmi Z
    Cell Immunol; 1989 Sep; 122(2):295-306. PubMed ID: 2788512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroids in human lymphocyte-mediated cytotoxic reactions: effects on the kinetics of sensitization and on the cytolytic capacity of effector lymphocytes in vitro.
    Balow JE; Hunninghake GW; Fauci AS
    Transplantation; 1977 Apr; 23(4):322-8. PubMed ID: 141115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging influence on the E-rosette forming cells, spontaneous cell mediated cytotoxicity, and antibody dependent cellular cytotoxicity in humans.
    Olinescu A; Hristescu S; Poliopol M; Vasiliu E; Saragea M; Saragea A; Perieteanu R
    Arch Immunol Ther Exp (Warsz); 1987; 35(1):1-10. PubMed ID: 3498459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chédiak-Higashi gene in humans. II. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function.
    Klein M; Roder J; Haliotis T; Korec S; Jett JR; Herberman RB; Katz P; Fauci AS
    J Exp Med; 1980 May; 151(5):1049-58. PubMed ID: 6966316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressed lectin-dependent and enhanced antibody-dependent cell-mediated cytotoxicity in patients with stage I cancer of the larynx.
    Perl A; Repassy G; Gonzalez-Cabello R; Lang I; Gergely P
    Nat Immun Cell Growth Regul; 1986; 5(2):100-6. PubMed ID: 3487714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-mediated induction in human lymphocytes of antibody-independent cytotoxicity (VDCC) and enhancement of antibody-dependent cytotoxicity (ADCC) against natural killer-resistant tumor target cells.
    Alsheikhly AR; Andersson T; Perlmann P
    Cell Immunol; 1984 Oct; 88(2):511-20. PubMed ID: 6488328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulation of human leukocytes by staphylococcal enterotoxin A: augmentation of natural killer cells and induction of suppressor cells.
    Platsoucas CD; Oleszak EL; Good RA
    Cell Immunol; 1986 Feb; 97(2):371-85. PubMed ID: 2943428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of cell-mediated cytotoxicity at the single-cell level. VII. Trigger of the lethal hit event is distinct for NK/K and LDCC effector cells as measured in the two-target conjugate assay.
    Bradley TP; Bonavida B
    Cell Immunol; 1984 Jan; 83(1):199-207. PubMed ID: 6420079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of antibody-dependent cellular cytotoxicity and mitogen-induced cellular cytotoxicity effector cell function in patients with acute myelogenous leukemia in remission.
    Zighelboim J
    Cancer Res; 1979 Sep; 39(9):3357-62. PubMed ID: 314332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immunity in aged mice: an underlying lesion in IL 2 synthesis.
    Thoman ML; Weigle WO
    J Immunol; 1982 May; 128(5):2358-61. PubMed ID: 6460821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A monoclonal anti-DC1 antibody selectivity inhibits the generation of effector T cells mediating specific cytolytic activity.
    Corte G; Moretta A; Cosulich ME; Ramarli D; Bargellesi A
    J Exp Med; 1982 Nov; 156(5):1539-44. PubMed ID: 6982307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector cell potential of two human T-cell subpopulations with different affinities to sheep erythrocytes.
    Hokland P; Heron I
    Scand J Immunol; 1980; 12(3):183-91. PubMed ID: 6451024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preservation of natural killer and interleukin-2 activated killer cell activity in ataxia-telangiectasia with T cell deficiency.
    Tsuge I; Matsuoka H; Torii S; Okada J; Mizuno T; Matsuoka M; Kodera Y; Takahashi T
    J Clin Lab Immunol; 1987 May; 23(1):7-13. PubMed ID: 3497277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.